1-13 of 13
Alexandra Bazeos
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Glofitamab (Glofit) Plus R-CHOP Has a Favorable Safety Profile and Induces High Response Rates in Patients with Previously Untreated (1L) Large B-Cell Lymphoma (LBCL) Defined As High Risk By Circulating Tumor DNA (ctDNA) Dynamics: Preliminary Safety and Efficacy Results

Lorenzo Falchi, Fabrice Jardin, Corinne Haioun, Tomasz Wrobel, Judit Mészáros Joergensen, Mariana Bastos-Oreiro, Eric Mou, Joaquin Martinez-Lopez, L. Elizabeth Budde, Nancy L. Bartlett, Jan M. Zaucha, Alejandro Martin Garcia-Sancho, Rutanshu Shah, Nathan Rees, Ron McCord, Alexandra Bazeos, Maneesh Tandon, Michelle Doral, Ethan Troy-Barnes, Marcel Nijland
Journal: Blood
Blood (2023) 142 (Supplement 1): 858.
https://doi.org/10.1182/blood-2023-173953
Published: 2023
Journal Articles

Immune Graft Composition Is Important for Deepening Response and Outcome after Autologous Stem Cell Transplantation in Patients with Multiple Myeloma Who Do Not Receive Maintenance Therapy

Yeasung Lee, Francesca Bladt, Dimitrios Leonardos, Chira Mustafa, Alexia Katsarou, Maria Atta, Marco Bua, Ian Gabriel, Jose Ros-Soto, Alexandra Bazeos, Jiri Pavlu, Sandra Loaiza, Emma Bray, Farah O'Boyle, Elisabet Nadal, Richard Szydlo, Nicholas Crump, Anastasios Karadimitris, Aristeidis Chaidos
Journal: Blood
Blood (2023) 142 (Supplement 1): 759.
https://doi.org/10.1182/blood-2023-188912
Published: 2023
Journal Articles

Characterizing Diffuse Large B Cell Lymphoma (DLBCL) Disease Biology Features and Survival Outcomes By Patient Racial Groups Using Real World Data

Hwai Jing Hiew, Yutong Liu, Spencer James, Sandhya Balasubramanian, Alexandra Bazeos, Yanrong Jiang
Journal: Blood
Blood (2022) 140 (Supplement 1): 9528–9529.
https://doi.org/10.1182/blood-2022-159423
Published: 2022
Journal Articles

A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma

Clinical Trials & Observations
Franck Morschhauser, Pierre Feugier, Ian W. Flinn, Robin Gasiorowski, Richard Greil, Árpád Illés, Nathalie A. Johnson, Jean-François Larouche, Pieternella J. Lugtenburg, Caterina Patti, Gilles A. Salles, Marek Trněný, Sven de Vos, Farheen Mir, Divya Samineni, Su Y. Kim, Yanwen Jiang, Elizabeth Punnoose, Arijit Sinha, Emma Clark, Nathalie Spielewoy, Kathryn Humphrey, Alexandra Bazeos, Andrew D. Zelenetz
Journal: Blood
Blood (2021) 137 (5): 600–609.
https://doi.org/10.1182/blood.2020006578
Published: 2021
Includes: Supplemental data
Journal Articles

Recapitulation of Prognostic Mutational Subtyping Utilizing F1H in GOYA and CAVALLI and the Potential to Highlight Benefit of Targeted Therapy in De Novo DLBCL

Eugene C Kim, PhD, Jinzhen Fan, PhD, Christopher R Bolen, PhD, Alexandra Bazeos, MD PhD FRCPath, Yanwen Jiang, PhD, Sandhya Balasubramanian, MS, Rama Balakrishnan, PhD, Andrea Knapp, PhD, Kathryn Humphrey, BSc, Tina G Nielsen, MD PhD, Jeffrey M. Venstrom, MD PhD, Genevive Hernandez, PhD, Joseph N Paulson, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2788.
https://doi.org/10.1182/blood-2019-124687
Published: 2019
Journal Articles

Low Peripheral Blood NK Cell Count Is Associated with Worse Clinical Outcome in Patients with Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results from the Frontline Phase 3 GALLIUM and GOYA Trials

Magdalena Klanova, MD, Mikkel Z. Oestergaard, Marek Trněný, MD PhD, Wolfgang Hiddemann, MD PhD, Robert Marcus, Laurie H. Sehn, MDMPH, Umberto Vitolo, MD, Alexandra Bazeos, Valentin Goede, MD, Harald Zeuner, Andrea Knapp, Denis Sahin, Nathalie Danesi, Christopher Bolen, Susan Robson, Jeffrey M. Venstrom, Tina Nielsen, Günter Fingerle-Rowson
Journal: Blood
Blood (2017) 130 (Supplement 1): 727.
https://doi.org/10.1182/blood.V130.Suppl_1.727.727
Published: 2017
Journal Articles

Mode of Progression after First Line Treatment Correlates with Outcome of Chronic Lymphocytic Leukemia (CLL)

Othman Al-Sawaf, MD, Alexandra Bazeos, Sandra Robrecht, PhD, Jasmin Bahlo, PhD, Anna Maria Fink, MD, Julia Von Tresckow, Paula Cramer, MD, Petra Langerbeins, MD, Nadine Kutsch, MD, Kathryn Humphrey, PhD, Günter Fingerle-Rowson, MD PhD, Stephan Stilgenbauer, MD PhD, Clemens-Martin Wendtner, MD, Kirsten Fischer, MD, Barbara F. Eichhorst, MD, Michael Hallek, MD, Valentin Goede, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1740.
https://doi.org/10.1182/blood.V130.Suppl_1.1740.1740
Published: 2017
Journal Articles

Progression By Lymphocytosis Correlates with Favourable Long-Term Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL)

Alexandra Bazeos, Craig Gower, Francine Swann, Peter C Trask, Mark Dixon, BSc MSC, Noelle Crompton, Nelson Kinnersley, Othman Al-Sawaf, MD, Valentin Goede, MD, Günter Fingerle-Rowson, Kathryn Humphrey, PhD
Journal: Blood
Blood (2016) 128 (22): 4352.
https://doi.org/10.1182/blood.V128.22.4352.4352
Published: 2016
Journal Articles

Somatic Mutations in Epigenetic Modifiers Identified Using Next Generation Sequencing (NGS) in Diagnostic Samples of CML-CP Can Predict Poor Outcome on Imatinib Which Is Abrogated By Frontline 2G-TKI Therapy

Georgios Nteliopoulos, MSc, PhD, Alexandra Bazeos, MB, BS, MRCP, Gareth Gerrard, PhD, Simone Claudiani, MD, Ed Curry, PhD, Mary Alikian, MSc, PhD, Hui En Foong, Letizia Foroni, MD PhD FRCPath, Jane F. Apperley, MD
Journal: Blood
Blood (2016) 128 (22): 1223.
https://doi.org/10.1182/blood.V128.22.1223.1223
Published: 2016
Journal Articles

Evaluation of Fatigue in Previously Untreated CLL Patients with Comorbidities Treated with Obinutuzumab (GA101) + Chlorambucil (GClb) or Rituximab + Chlorambucil (RClb)

Valentin Goede, MD, Peter C Trask, Katharina Ziesel, Marianne Uguen, MSc, Alexandra Bazeos, Kirsten Fischer, MD, Michael Hallek, MD
Journal: Blood
Blood (2016) 128 (22): 2401.
https://doi.org/10.1182/blood.V128.22.2401.2401
Published: 2016
Journal Articles

Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling

Hugues de Lavallade, Ahmad Khoder, Melanie Hart, Anushruti Sarvaria, Takuya Sekine, Abdullah Alsuliman, Stephan Mielke, Alexandra Bazeos, Kate Stringaris, Sara Ali, Dragana Milojkovic, Letizia Foroni, Aristeidis Chaidos, Nichola Cooper, Ian Gabriel, Jane Apperley, Sarah Belsey, Robert J. Flanagan, John Goldman, Elizabeth J. Shpall, Peter Kelleher, David Marin, Katayoun Rezvani
Journal: Blood
Blood (2013) 122 (2): 227–238.
https://doi.org/10.1182/blood-2012-11-465039
Published: 2013
Includes: Supplemental data
Journal Articles

Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitor Have Normal T Cell Responses to Vaccination but An Impaired IgM Humoral Response Associated with Loss of Discrete Memory B Cell Subsets,

Hugues de Lavallade, MD, David Marin, Melanie Hart, Takuya Sekine, Ian Gabriel, MD, Abdullah Alsuliman, Alexandra Bazeos, Ahmad Khoder, Dr, Kate Stringaris, MD, MRCP, FRCPath, Jamshid Khorashad, MD, PhD, Nichola Cooper, MD, Dragana Milojkovic, MD, Letizia Foroni, MD PhD, Richard M Szydlo, Aristeidis Chaidos, Amr R Ibrahim, Marco Bua, MD, John M Goldman, Jane F Apperley, MBChB, MD, FRCP, FRCPath, William P Kelleher, MD, PhD, Katayoun Rezvani
Journal: Blood
Blood (2011) 118 (21): 3753.
https://doi.org/10.1182/blood.V118.21.3753.3753
Published: 2011
Journal Articles

BCR-ABL1 Oncogene Down-regulates the Expression of OCT1 in CML.

Alexandra Bazeos, David Marin, Gareth Gerrard, PhD, Richard Szydlo, Dragana Milojkovic, MD, Alistair Reid, Hugues de Lavallade, Jane F. Apperley, MBChB, FRCP, FRCPath, John M Goldman, DM, FCRP, FRCPath, Letizia Foroni, Jamshid Sorouri Khorashad, MD
Journal: Blood
Blood (2009) 114 (22): 3248.
https://doi.org/10.1182/blood.V114.22.3248.3248
Published: 2009